Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Recruiting · NCT06841679 · Registry updated 2025-11-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric or Gastroesophageal Junction Adenocarcinoma | Recruiting | Phase 2 / Phase 3 | 2025-11-25 | NCT06841679 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Biostar Pharmaceuticals Co., Ltd. | 9 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anyang Tumor Hospital | Anyang | China | 2 |
| BioResearch Partner | Hialeah | United States | 7 |
| Henan Cancer Hospital | Zhengzhou | China | 60 |
| Jinan Municipal Central Hospital | Jinan | China | 1 |
| Liaoning Cancer Hospital | Shenyang | China | 14 |
| Shandong First Medical University Affiliated Tumor Hospital | Jinan | China | 2 |
| Shanxi Cancer Hospital | Taiyuan | China | 17 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 50 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 37 |